High or low risk coronary patients - who gets the highest priority?
Coronary revascularisation is more often used in patients at small risk and with little to gain than in patients at high risk and much to gain. This is against current guide-lines and is wasteful. The problem if aggravated by socioeconomic bias. A redesigned reimbursement system, based on measured improved quality of life and survival, would encourage a more efficient use of resources.
Ekroth
Rolf
R
Ståhle
Elisabeth
E
D003327:Coronary Disease / Q000191:economics / Q000453:epidemiology / Q000628:therapy*; D003920:Diabetes Mellitus / Q000453:epidemiology; D017048:Health Care Costs; D015276:Health Care Rationing / Q000191:economics; D006292:Health Priorities / Q000191:economics; D006295:Health Resources / Q000191:economics / Q000600:supply & distribution; D006297:Health Services Accessibility / Q000191:economics; D054625:Healthcare Disparities / Q000191:economics; D006801:Humans; D007349:Insurance, Health, Reimbursement; D009204:Myocardial Revascularization / Q000009:adverse effects / Q000191:economics / Q000706:statistics & numerical data*; D018579:Patient Selection; D017410:Practice Guidelines as Topic; D018570:Risk Assessment; D012307:Risk Factors; D012959:Socioeconomic Factors; D013997:Time Factors; D016896:Treatment Outcome